Trial intelligence / Profile preview

Effect of mosapride on rectosigmoid sensorimotor function in IBS

jRCT1091220040Completed

Sponsor
Shin Fukudo
Start
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Mosapride citrate arm with Placebo arm (2 arms). Primary endpoint: Rectosigmoid motility. Started Jun 2010; status: completed.

02

Drugs

mosapride
03

Conditions

irritable bowel syndrome (IBS)

Beyond the preview

Go deeper on jRCT1091220040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call